戻る Agenda
Session 2: Metrics Maturity Model
Session Chair(s)
Linda B Sullivan, MBA
Senior Fellow
Tufts Center For the Study of Drug Development, United States
Some organizations have robust metric programs and use metrics to support process improvement programs – others use a small number of metrics primarily for program oversight. In this session, what organizations measure and how they use the results will be described in the context of a five-stage metrics maturity model. The characteristics of each stage will be explored as well as the concept of basic, advanced, and exploratory metrics. Throughout the conference participants will use the framework to keep track of metrics described in conference sessions – determining whether they are examples of basic, advanced, or exploratory metrics and to which stage of the framework they align.
Learning Objective : At the conclusion of this session, participants should be able to:- Explain how metric programs evolve through the metric maturity model stages
- Describe the difference between basic, advanced, and exploratory metrics
- Apply the metric maturity model to measuring the impact of patient-centered drug development approaches
Speaker(s)
Metrics Maturity Model
Linda B Sullivan, MBA
Tufts Center For the Study of Drug Development, United States
Senior Fellow